litlas
ログインアカウント作成

J. Randolph Hecht

1998–2026 年に発表

79
論文数
20,839
被引用数
53
h 指数
70
i10 指数

被引用数

J. Randolph Hecht の年別被引用数1985 年: 被引用 1 件1990 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 1 件2001 年: 被引用 4 件2002 年: 被引用 3 件2003 年: 被引用 12 件2004 年: 被引用 30 件2005 年: 被引用 59 件2006 年: 被引用 96 件2007 年: 被引用 139 件2008 年: 被引用 104 件2009 年: 被引用 155 件2010 年: 被引用 201 件2011 年: 被引用 166 件2012 年: 被引用 184 件2013 年: 被引用 206 件2014 年: 被引用 206 件2015 年: 被引用 220 件2016 年: 被引用 211 件2017 年: 被引用 207 件2018 年: 被引用 169 件2019 年: 被引用 513 件2020 年: 被引用 461 件2021 年: 被引用 500 件2022 年: 被引用 451 件2023 年: 被引用 317 件2024 年: 被引用 654 件2025 年: 被引用 375 件2026 年: 被引用 16 件1986〜1989 年は被引用が無いため表示していません1991〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,142 件、この内訳の 26.5%中国: 引用元論文 952 件、この内訳の 11.8%イタリア: 引用元論文 518 件、この内訳の 6.4%イギリス: 引用元論文 487 件、この内訳の 6%ドイツ: 引用元論文 455 件、この内訳の 5.6%フランス: 引用元論文 373 件、この内訳の 4.6%日本: 引用元論文 366 件、この内訳の 4.5%スペイン: 引用元論文 310 件、この内訳の 3.9%オランダ: 引用元論文 243 件、この内訳の 3%カナダ: 引用元論文 211 件、この内訳の 2.6%オーストラリア: 引用元論文 198 件、この内訳の 2.5%韓国: 引用元論文 181 件、この内訳の 2.3%
0%26.5%その他 20.3%

機関

分野

  • Medicine65.7%
  • Biochemistry, Genetics and Molecular Biology26.8%
  • Immunology and Microbiology3%
  • Materials Science0.8%
  • Computer Science0.7%
  • Engineering0.7%
  • その他2.3%

トピック

  • Colorectal Cancer Treatments and Studies7.8%
  • Cancer Genomics and Diagnostics6.3%
  • Pancreatic and Hepatic Oncology Research5.4%
  • Colorectal Cancer Surgical Treatments3.2%
  • Lung Cancer Treatments and Mutations3.1%
  • Cancer Immunotherapy and Biomarkers2.9%
  • その他71.3%

共著者

全論文

検索で開く
  1. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    著者: Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Mustafa A. Arain, Yi‐Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Linda M. Farkas, Ignacio Garrido‐Laguna, Jean L. Grem, Andrew J. Gunn, J. Randolph Hecht, Sarah E. Hoffe, Joleen M. Hubbard, Steven R. Hunt, Kimberly L. Johung, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, Steven Nurkin, Michael J. Overman, Aparna R. Parikh, Hitendra Patel, Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Kristina M. Gregory, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2021 被引用: 1,748

  2. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

    著者: Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Nilofer Azad, Yi‐Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Ignacio Garrido‐Laguna, Jean L. Grem, Andrew J. Gunn, J. Randolph Hecht, Sarah E. Hoffe, Joleen M. Hubbard, Steven R. Hunt, William R. Jeck, Kimberly L. Johung, Natalie Kirilcuk, Smitha Krishnamurthi, Jennifer K. Maratt, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, Steven Nurkin, Michael J. Overman, Aparna Parikh, Hitendra Patel, Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Eden Stotsky‐Himelfarb, Anna Tavakkoli, Christopher G. Willett, Kristina M. Gregory, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2022 被引用: 819

  3. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

    著者: Malcolm J. Moore, David Goldstein, John Hamm, Arié Figer, J. Randolph Hecht, Steven Gallinger, H. Au, P. Murawa, David Walde, Robert A. Wolff, Daniel de Castro, Robert Lim, Keyue Ding, Gary M. Clark, Theodora Voskoglou-Nomikos, Mieke Ptasynski, Wendy R. Parulekar - Journal of Clinical Oncology 2007 被引用: 3,859

  4. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

    著者: Luis A. Díaz, Richard T. Williams, Jian Wu, Isaac Kinde, J. Randolph Hecht, Jordan Berlin, Benjamin Allen, Ivana Božić, Johannes G. Reiter, Martin A. Nowak, Kenneth W. Kinzler, Kelly S. Oliner, Bert Vogelstein - Nature 2012 被引用: 1,748

  5. A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results

    著者: Amy Rappaport, Chrisann Kyi, Monica Lane, Meghan G. Hart, Melissa L. Johnson, Brian S. Henick, Chih‐Yi Liao, Amit Mahipal, Ardaman Shergill, Alexander I. Spira, Jonathan W. Goldman, Ciaran D. Scallan, Desiree Schenk, Christine D. Palmer, Matthew J. Davis, Sonia Kounlavouth, Lindsey Kemp, Aaron Yang, Y. Li, Molly Likes, Annie Shen, Gregory R. Boucher, Milana Egorova, Robert L. Veres, J. Aaron Espinosa, Jason R. Jaroslavsky, Lauren D. Kraemer Tardif, Lindsey Acrebuche, Christopher Puccia, Leiliane Sousa, Rita Zhou, Kyounghwa Bae, J. Randolph Hecht, David P. Carbone, Benny Johnson, Andrew M. Allen, Andrew R. Ferguson, Karin Jooss - Nature Medicine 2024 被引用: 127

  6. Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer

    著者: Scott Kopetz, Jayesh Desai, Emily Chan, J. Randolph Hecht, Peter J. O’Dwyer, Dipen M. Maru, Van K. Morris, Filip Jankú, Arvind Dasari, Woonbok Chung, Jean‐Pierre J. Issa, Peter Gibbs, Brian P. James, Garth Powis, K. B. Nolop, Suman Bhattacharya, Leonard B. Saltz - Journal of Clinical Oncology 2015 被引用: 693

  7. A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma

    著者: Al B. Benson, Zev A. Wainberg, J. Randolph Hecht, Dmitry Vyushkov, Hua Dong, Johanna C. Bendell, Fred J. Kudrik - The Oncologist 2017 被引用: 176

  8. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

    著者: Al B. Benson, Alan P. Venook, Mohamed A. Adam, George J. Chang, Yi-Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Ignacio Garrido‐Laguna, Jean L. Grem, Paul Haste, J. Randolph Hecht, Sarah E. Hoffe, Steven R. Hunt, Hisham Hussan, Kimberly L. Johung, Nora Joseph, Natalie Kirilcuk, Smitha Krishnamurthi, Midhun Malla, Jennifer K. Maratt, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, Steven Nurkin, Michael J. Overman, Aparna Parikh, Hitendra Patel, Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, Benjamin D. Shogan, John M. Skibber, Constantinos T. Sofocleous, Anna Tavakkoli, Christopher G. Willett, Christina Wu, Lisa A. Gurski, Jenna Snedeker, Frankie Jones - Journal of the National Comprehensive Cancer Network 2024 被引用: 308

  9. Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial

    著者: J. Randolph Hecht, Yung‐Jue Bang, Shukui Qin, Hyun Cheol Chung, Jianming Xu, Joon Oh Park, Krzysztof Jeziorski, Yaroslav Shparyk, Paulo M. Hoff, Alberto Sobrero, Pamela Salman, Jin Li, Светлана Проценко, Zev A. Wainberg, Marc Buyse, Karen Afenjar, Vincent Houé, Agathe Garcia, Tomomi Kaneko, Yingjie Huang, S. Khan‐Wasti, Sergio Santillana, Michael F. Press, Dennis J. Slamon - Journal of Clinical Oncology 2015 被引用: 621

  10. A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma

    著者: J. Randolph Hecht, Al B. Benson, Dmitry Vyushkov, Yingsi Yang, Johanna C. Bendell, Udit Verma - The Oncologist 2017 被引用: 126

  11. NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024

    著者: Al B. Benson, Alan P. Venook, Mohamed A. Adam, George J. Chang, Yi-Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Ignacio Garrido‐Laguna, Jean L. Grem, Paul Haste, J. Randolph Hecht, Sarah E. Hoffe, Steven R. Hunt, Hisham Hussan, Kimberly L. Johung, Nora Joseph, Natalie Kirilcuk, Smitha Krishnamurthi, Midhun Malla, Jennifer K. Maratt, Wells A. Messersmith, Jeffrey A. Meyerhardt, Eric D. Miller, Mary F. Mulcahy, Steven Nurkin, Aparna Parikh, Hitendra Patel, Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, Benjamin D. Shogan, John M. Skibber, Constantinos T. Sofocleous, Anna Tavakkoli, Christopher G. Willett, Christina Wu, Frankie Jones, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2024 被引用: 215

  12. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

    著者: Aimery de Gramont, Eric Van Cutsem, Hans‐Joachim Schmoll, Josep Tabernero, Stephen Clarke, Malcolm J. Moore, David Cunningham, Thomas H. Cartwright, J. Randolph Hecht, Fernando Rivera, Seock‐Ah Im, G. Bodoky, Ramón Salazar, Frédérique Maindrault-Goebel, Einat Shacham‐Shmueli, Emilio Bajetta, Martina Makrutzki, Aijing Shang, Thierry André, Paulo M. Hoff - The Lancet Oncology 2012 被引用: 526

  13. Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)

    著者: J. Randolph Hecht, Sara Lonardi, Johanna C. Bendell, Hao‐Wen Sim, Teresa Macarulla, Charles D. Lopez, Eric Van Cutsem, Andrés J. Muñoz Martín, Joon Oh Park, Richard Greil, Hong Wang, Rebecca R. Hozak, Ivelina Gueorguieva, Yong Lin, Sujata Rao, Baek‐Yeol Ryoo - Journal of Clinical Oncology 2021 被引用: 110

  14. Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

    著者: J. Randolph Hecht, Steven S. Raman, Arlene Chan, Kevin Kalinsky, Jean‐François Baurain, M.M. Jimenez, Maria Martinez‐García, Martin D. Berger, Ulrich M. Lauer, A. Khattak, Alfredo Carrato, Yue Zhang, K. Liu, Edward Cha, Alissa Keegan, Sumita Bhatta, C.P. Strassburg, Aflah Roohullah - ESMO Open 2023 被引用: 39

  15. Safety, efficacy, and on-treatment circulating tumor DNA (ctDNA) changes from a phase 1 study of RMC-6236, a RAS(ON) multi-selective, tri-complex inhibitor, in patients with RAS mutant pancreatic ductal adenocarcinoma (PDAC).

    著者: Ignacio Garrido‐Laguna, Brian M. Wolpin, Wungki Park, Nilofer S. Azad, Alexander I. Spira, Alexander Starodub, David Sommerhalder, Salman R. Punekar, Benjamin Herzberg, Minal Barve, Meredith S. Pelster, Jennifer Brooke Valerin, J. Randolph Hecht, Rashmi Vora, Aparna Hegde, Clay Gustafson, Tao Lin, Sumit Kar, Kevin Lin, David S. Hong - Journal of Clinical Oncology 2025 被引用: 39

  16. A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer

    著者: J. Randolph Hecht, Edith P. Mitchell, Tarek Chidiac, Carroll Scroggin, Christopher Hagenstad, David R. Spigel, John L. Marshall, Allen Lee Cohn, David McCollum, Philip J. Stella, Robert G Deeter, Seta Shahin, Rafael G. Amado - Journal of Clinical Oncology 2008 被引用: 852

  17. Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer

    著者: Efrat Dotan, Steven J. Cohen, Alexander Starodub, Christopher H. Lieu, Wells A. Messersmith, Pamela S. Simpson, Michael J. Guarino, John L. Marshall, Richard M. Goldberg, J. Randolph Hecht, William A. Wegener, Robert M. Sharkey, Serengulam V. Govindan, David M. Goldenberg, Jordan Berlin - Journal of Clinical Oncology 2017 被引用: 118

  18. A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients.

    著者: George A. Fisher, Nehal J. Lakhani, Cathy Eng, J. Randolph Hecht, Johanna C. Bendell, Philip Agop Philip, Peter J. O’Dwyer, Benny Johnson, Adel Kardosh, Tina M Ippolito, Yan V. Wang, Balaji Agoram, Jens-Peter Volkmer, Roy L. Maute, Isagani Chico, Mark P. Chao, Chris H. Takimoto, Amita Patnaik - Journal of Clinical Oncology 2020 被引用: 53

  19. Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial

    著者: Fairooz F. Kabbinavar, Joseph J. Schulz, Michael McCleod, Taral Patel, John Hamm, J. Randolph Hecht, R. Mass, B. Perrou, B. Nelson, William Novotny - Journal of Clinical Oncology 2005 被引用: 933

  20. PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer

    著者: Lee S. Schwartzberg, Fernando Rivera, Meinolf Karthaus, Gianpiero Fasola, Jean-Luc Canon, J. Randolph Hecht, Hua Yu, Kelly S. Oliner, William Y. Go - Journal of Clinical Oncology 2014 被引用: 632

  21. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma.

    著者: J. Randolph Hecht, Rudolph A. Bedford, James L. Abbruzzese, Sandeep Lahoti, Tony R. Reid, Roy Soetikno, David H. Kirn, Sara M. Freeman - 2003 被引用: 496

  22. Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project

    著者: Katrin Marie Sjoquist, Lindsay A. Renfro, R. John Simes, Niall C. Tebbutt, Stephen Clarke, Michel Seymour, Richard Adams, Tim Maughan, Leonard B. Saltz, Richard M. Goldberg, Hans‐Joachim Schmoll, Eric Van Cutsem, Jean‐Yves Douillard, Paulo M. Hoff, J. Randolph Hecht, Christophe Tournigand, Cornelis J.A. Punt, Miriam Koopman, Herbert I. Hurwitz, Volker Heinemann, Alfredo Falcone, Rainer Porschen, Charles S. Fuchs, Eduardo Díaz‐Rubio, Enrique Aranda, Carsten Bokemeyer, Ioannis Souglakos, Fairooz F. Kabbinavar, Benoist Chibaudel, Jeffrey P. Meyers, Daniel J. Sargent, Aimery de Gramont, John Zalcberg, The Fondation Aide et Recherche en Cancerologie Digestive Group (ARCAD) - JNCI Journal of the National Cancer Institute 2017 被引用: 144

  23. Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

    著者: Charles D. Blanke, Cathryn Rankin, George D. Demetri, Christopher W. Ryan, Margaret von Mehren, Robert S. Benjamin, A. Kevin Raymond, Vivien Bramwell, Laurence H. Baker, Robert G. Maki, Michael Tanaka, J. Randolph Hecht, Michael C. Heinrich, Christopher D.�M. Fletcher, John J. Crowley, Ernest C. Borden - Journal of Clinical Oncology 2008 被引用: 1,077

  24. Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer

    著者: Michael P. Chu, J. Randolph Hecht, Dennis J. Slamon, Zev A. Wainberg, Yung‐Jue Bang, Paulo M. Hoff, Alberto F. Sobrero, Shukui Qin, Karen Afenjar, Vincent Houé, Karen L. King, Sheryl Koski, Karen Mulder, Julie Price Hiller, Andrew Scarfe, Jennifer L. Spratlin, Yingjie Huang, S. Khan‐Wasti, Neil Chua, Michael B. Sawyer - JAMA Oncology 2016 被引用: 106